Light-emitting diodes as a light source for intraoperative photodynamic therapy

Neurosurgery

Volumn 38, Issue 3, 1996, Pages 552-557

  Schmidt, Meic H ^a   Bajic, Dawn M ^a   Reichert II, Kenneth W ^a   Martin, Todd S ^b   Meyer, Glenn A ^a   Whelan, Harry T ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Quantum Devices   (United States)

Author keywords

Brain tumor therapy; Instrumentation; Laser; Light source; Light emitting diodes; Photodynamic therapy; Photofrin

Indexed keywords

PHOTOFRIN;

ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DOG; INTRAOPERATIVE PERIOD; LASER; LIGHT EMITTING DIODE; LIGHT EXPOSURE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SEMICONDUCTOR;

NON-PROGRAMMATIC;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DOGS; EQUIPMENT DESIGN; HEMATOPORPHYRIN PHOTORADIATION;

EID: 0030041441     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006123-199603000-00025     Document Type: Article

References (30)

1. Barta DJ, Tibbitts TW, Bula RJ, Morrow RC: Evaluation of light-emitting diode characteristics for a space-based plant irradiation source. Adv Space Res 12:141-149, 1992.
2. Bula RJ, Morrow RC, Tibbitts TW, Barta DJ, Ignatius RW, Martin TS: Light-emitting diodes as a radiation source for plants. Hortic Sci (Calcutta) 26:203-205, 1991.
3. Eggert HR, Blazek V: Optical properties of human brain tissue, meninges, and brain tumors in the spectral range of 200 to 900 nm. Neurosurgery 21:459-464, 1987.
4. Eggert HR, Blazek V: Optical properties of normal human intracranial tissues in the spectral range of 400 to 2500 nm. Adv Exp Med Biol 333:47-55, 1993.
5. Fingar VH, Henderson BW: Drug and light dose dependence of photodynamic therapy: A study of tumor and normal response. Photochem Photobiol 46:837-841, 1987.
6. Fingar VH, Potter WR, Henderson BW: Drug and light dose dependence of photodynamic therapy: A study of cell clonogenicity and histologic changes. Photochem Photobiol 45:643-650, 1987.
7. Heier SK, Heier LM: Tissue sensitizers. Gastrointest Endosc Clin N Am 4:327-352, 1994.
8. Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 55:145-157, 1992.
9. Hill JS, Kaye AH, Sawyer WH, Morstyn G, Megison PD, Stylli S: Selective uptake of haematoporphyrin derivative into human cerebral glioma. Neurosurgery 26:248-254, 1990.
10. Ji Y, Walstad D, Brown JT, Powers SK: Improved survival from intracavitary photodynamic therapy of rat glioma. Photochem Photobiol 56:385-390, 1992.
11. Kaye AH, Morstyn G, Apuzzo MLJ: Photoradiation therapy and its potential in the management of neurological tumours. J Neurosurg 69:1-14, 1988.
12. Kaye AH, Morstyn G, Ashcroft RG: The uptake and retention of haematoporphyrin derivative in an in vitro and in vivo model of glioma. Neurosurgery 17:883-890, 1985.
13. Kaye AH, Morstyn G, Brownbill D: Adjuvant high-dose photoradiation therapy in the treatment of cerebral glioma: A phase 1-2 study. J Neurosurg 67:500-505, 1987.
14. Kostron H, Weiser G, Fritsch E, Grunert V: Photodynamic therapy of malignant brain tumors: Clinical and neuropathological results. Photochem Photobiol 46:937-943, 1987.
15. Laws ER Jr, Cortese DA, Kinsey JH, Eagan RT, Anderson RE: Photoradiation therapy in the treatment of malignant brain tumors: A phase I (feasibility) study. Neurosurgery 9:672-678, 1981.
16. Leach MW, Khoshyomn S, Bringus J, Autry SA, Boggan JE: Normal brain tissue response to photodynamic therapy using aluminum phthalocyanine tetrasulfonate in the rat. Photochem Photobiol 57:842-845, 1993.
17. Lindsay EA, Berenbaum MC, Bonnett R, Thomas DG: Photodynamic therapy of a mouse glioma: Intracranial tumours are resistant while subcutaneous rumours are sensitive. Br J Cancer 63: 242-246, 1991.
18. Muller PJ, Wilson BC: Photodynamic therapy: Cavitary photoillumination of malignant cerebral tumours using a laser coupled inflatable balloon. Can J Neurol Sci 12:371-373, 1985.
19. Muller PJ, Wilson BC: An update on the penetration depth of 630 nm light in normal and malignant human brain tissue in vivo. Phys Med Biol 31:1295-1297, 1986.
20. Muller PJ, Wilson BC: Photodynamic therapy of malignant primary brain tumours: Clinical effects, post-operative ICP, and light penetration of the brain. Photochem Photobiol 46:929-935, 1987.
21. Muller PJ, Wilson BC: Photodynamic therapy of malignant brain tumours. Can J Neurol Sci 17:193-198, 1990.
22. Origitano TC, Caron MJ, Reichman OH: Photodynamic therapy for intracranial neoplasms: Literature review and institutional experience. Mol Chem Neuropathol 21:337-352, 1994.
23. Powers SK, Cush SS, Walstad DL, Kwock L: Stereotactic intratumoral photodynamic therapy for recurrent malignant brain tumors. Neurosurgery 29:688-695, 1991.
24. Schmidt MH: Intraoperative photodynamic therapy in a posterior fossa brain tumor model. Medical College of Wisconsin, 1994 (dissertation).
25. Tennessen DJ, Singsaas EL, Sharkey TD: Light-emitting diodes as a light source for photosynthesis research. Photosynth Res 39:85-92, 1994.
26. van Lier JE, Spikes JD: The chemistry, photophysics and photosensitizing properties of phthalocyanines. Ciba Found Symp 146: 17-27, 1989.
27. Waterfield EM, Renke ME, Smits CB, Gervais MD, Bower RD, Stonefield MS, Levy JG: Wavelength-dependent effects of benzoporphyrin derivative monoacid ring A in vivo and in vitro. Photochem Photobiol 60:383-387, 1994.
28. 111In-labeled Photofrin by glioma tissue in vivo. J Neurooncol 22:7-13, 1994.
29. Whelan HT, Schmidt MH, Segura AD, McAuliffe TL, Bajic DM, Murray KJ, Moulder JE, Strother DR, Thomas JP, Meyer GA: The role of photodynamic therapy in posterior fossa brain tumors: A pre-clinical study in a canine glioma model. J Neurosurg 79:562-568, 1993.
30. Wilson BC, Muller PJ, Yanch JC: Instrumentation and light dosimetry for intraoperative photodynamic therapy (PDT) of malignant brain tumours. Phys Med Biol 31:125-133, 1986.